Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-05-01
2007-05-01
Riley, Jezia (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C514S04400A, C435S006120
Reexamination Certificate
active
10932841
ABSTRACT:
The present invention provides compounds having the formula:wherein A is CH or N; B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H, halogen or SCH3; R is an optionally substituted alkyl, aralkyl or aryl group; and X and Y are independently selected from H, OH or halogen except that when one of X and Y is hydroxy or halogen, the other is hydrogen; and Z is OH or, when X is hydroxy, Z is selected from hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof; and compounds having the formula:wherein A, X, Y, Z and R are defined for compounds of formula (I) where first shown above; E is chosen from CO2H or a corresponding salt form, CO2R, CN, CONH2, CONHR or CONR2; and G is chosen from NH2, NHCOR, NHCONHR or NHCSNHR; or a tautomer thereof, or a pharmaceutically acceptable salt thereof, or an ester thereof, or a prodrug thereof.The present invention also provides the use of the above compounds as pharmaceuticals, pharmaceutical compositions containing the compounds and processes for preparing the compounds.
REFERENCES:
patent: 4711955 (1987-12-01), Ward et al.
patent: 5223618 (1993-06-01), Cook et al.
patent: 5466786 (1995-11-01), Buhr et al.
patent: 5506351 (1996-04-01), McGee
patent: 5985848 (1999-11-01), Furneaux et al.
patent: 6066722 (2000-05-01), Furneaux et al.
patent: 6228847 (2001-05-01), Furneaux et al.
patent: 6492347 (2002-12-01), Furneaux et al.
patent: 6803455 (2004-10-01), Furneaux et al.
Furneaux R. H., entitled “Synthesis of Transition State Inhibitors for N-Riboside Hydrolases and Transferases,” Tetrahedron, vol. 53, No. 8, pp. 2915-2930, 1997.
Yan, Jieming et al., entitled “High Performance liquid chromatographic determination of 9-(3-pyridylmethyl)-9-deazaguanine (BCX-34) in biological fluids,” Journal of Chromatography B. 690 (1997) 295-303.
Bols, Michael entitled “Synthesis of a Ribofuranosyl Cation Mimic,” Tetrahedron Letters, vol. 37, No. 12, pp. 2097-2100, 1996.
Miles, Robert W et al., entitled “One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorylase,” Biochemistry, vol. 37, No. 24, 1998, pp. 8615-8621.
Kline, et al., Pre-Steady-State Transition-State Analysis of the Hydrolytic Reaction Catalyzed by Purine Nuceloside Phosphorylase, Biochemistry 1995, 34, 1153-1162.
Furneaux Richard Hubert
Schramm Vern L.
Tyler Peter Charles
Albert Einstein College of Medicine of Yeshiva University
Amster Rothstein & Ebenstein LLP
Industrial Research Limited
Riley Jezia
LandOfFree
Inhibitors of nucleoside metabolism does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of nucleoside metabolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of nucleoside metabolism will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3739436